Is AtriCure Inc (ATRC) overvalued? · rev $465.3M
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
This page asks whether AtriCure Inc (ATRC) looks expensive on cached numbers — not a short thesis.
Latest reported ATRC revenue for 2024-12-31 was $465.3M. Net income was -$44.7M. Revenue was up 16.5% from 2023-12-31 to 2024-12-31. ATRC currently screens at market cap $1.37B.
ATRC currently screens at market cap $1.37B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ATRC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ATRC stock page for the full model, not this heading.
Not investment advice.